PhRMA lawsuit challenging IRA price negotiations dismissed on jurisdictional technicality

In a decision that bodes well for the Biden administration’s push to rein in drug prices, a federal judge in Texas has tossed a lawsuit from industry lobbying group PhRMA which challenged the legality of Medicare price negotiations as drawn up in the Inflation Reduction Act (IRA).